Thursday, January 9, 2024
12:00PM – 1:00PM ET
Please note this TeleECHO program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.
PRESENTING FACULTY
 |
Jerry Bagel, MD Clinical Professor of Dermatology Mt. Sinai School of Medicine Clinical Associate Professor of Dermatology University Of Pisa Director for the Psoriasis Treatment Center of Central New Jersey East Windsor, New Jersey |
PROGRAM DESCRIPTION
This program will focus on assessing treatment options with different mechanisms of actions for patients who are suffering from moderate-to-severe plaque psoriasis. Furthermore, TYK2 inhibitor treatment will be reviewed to determine if patients with moderate-to-severe plaque psoriasis may benefit from these treatment approaches. Lastly, we will review the importance of shared decision-making and the role it plays in this patient population.
TARGET AUDIENCE
This activity is designed to meet the educational needs of U.S.-based dermatologists, dermatology nurse practitioners, dermatology physician assistants, and Primary Care Physicians involved in the management of patients with psoriasis.
LEARNING OBJECTIVES
- Interpret results from studies assessing treatment options with different mechanisms of action for patients with moderate-to-severe plaque psoriasis
- Identify patients with moderate-to-severe plaque psoriasis who may benefit from a TYK2 inhibitor
- Incorporate SDM into treatment planning for patients with moderate-to-severe plaque psoriasis
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education (CE) for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture the faculty may mention the use of medications for both US Food and Drug Administration (FDA)-approved and non-FDA-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science-based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
